Lifestyle
- Regular physical activity
- Adequate hydration
- Stress management
Serum Albumin · ALB
Albumin measures the concentration of serum albumin, a protein synthesized by the liver, in the blood.
Reference ranges may vary slightly based on laboratory standards.
Albumin, also known as serum albumin, is the most abundant protein in human blood plasma. It is primarily synthesized in the liver and plays a crucial role in maintaining oncotic pressure, which is essential for the distribution of body fluids between body compartments. Albumin also serves as a carrier protein for hormones, vitamins, and drugs, and acts as a major antioxidant in the extracellular space. Clinically, albumin levels are indicative of liver function, nutritional status, and systemic inflammation. Hypoalbuminemia, or low serum albumin levels, can reflect conditions such as liver disease, kidney disease, malnutrition, and chronic inflammation. It is associated with poor outcomes in critically ill patients and may predict cardiovascular events and cognitive impairment. For athletes and biohackers, maintaining optimal albumin levels is important for recovery and overall health, as it influences fluid balance and nutrient transport. However, albumin levels can be affected by various factors, including hydration status, acute illness, and protein intake. Researchers found that albumin infusion does not necessarily improve outcomes in hypoalbuminemic patients, suggesting that addressing underlying causes of inflammation is more effective. Time-of-day and fasting status do not significantly affect albumin levels, but acute illness and hydration status can confound results. Therefore, interpreting albumin levels requires consideration of the clinical context and potential confounding factors.
Klinische Bedeutung
Reduced albumin levels indicate potential liver dysfunction, malnutrition, or systemic inflammation. Elevated levels are less common and may indicate dehydration or high protein intake.
Progressively rising albumin levels may suggest dehydration or high protein intake. Re-test if levels exceed the upper reference range.
Falling albumin levels may indicate worsening liver function or increased inflammation.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider for personalized advice, especially if underlying conditions are suspected.
Testing Frequency
Annually for general health monitoring, more frequently if managing chronic conditions.
Current research suggests that reference ranges for serum albumin in specific populations, such as pregnant women, remain poorly defined, and the optimal targets for albumin levels in critically ill patients are debated. Researchers have not yet established the mechanistic role of serum albumin in cognitive impairment related to white matter hyperintensities. Additionally, clinical questions regarding the impact of serum albumin's redox state on patient outcomes and the appropriateness of routine albumin level monitoring in various settings remain unanswered.
2,104
Total Citations
16
Human/RCT
6.7
Avg. Influence
2025
Latest
Researchers found that hypoalbuminemia is linked to inflammation and reflects the inflammatory state, which can negatively impact recovery from surgeries and chemotherapy. They observed that managing hypoalbuminemia should focus on addressing the underlying causes of inflammation rather than simply infusing albumin. Additionally, they noted that muscle mass loss after age 30 is associated with decreasing serum albumin levels.
This review discussed the process of glycation of human serum albumin and its implications in diabetes. Researchers highlighted the potential of glycated albumin as a marker for glycemic control and examined its effects on drug binding and clinical significance.
Researchers reviewed the prognostic significance of serum albumin levels across various clinical settings. They found that low serum albumin levels are associated with poor outcomes in conditions such as liver disease and COVID-19, suggesting that serum albumin can be a valuable biomarker for assessing patient prognosis.
Researchers explored the redox states of serum albumin and its implications for health. They found that the redox state of albumin serves as a biomarker for systemic oxidative stress and can shift in response to various diseases. The study suggests that oxidized albumin may exacerbate pathological conditions, highlighting the need for further investigation.
This study found that low serum albumin levels in end-stage renal disease patients are linked to increased mortality risk, particularly in the presence of systemic inflammation. Researchers concluded that serum albumin should not be used alone to assess nutritional status in these patients.
Researchers reviewed the biochemical changes induced by glycation of albumin and its implications for diabetes management. They found that high levels of glycated albumin are associated with long-term complications of diabetes and discussed its potential as a complementary biomarker for diabetes diagnosis and monitoring.
Researchers reviewed the prognostic significance of serum albumin levels in patients with hepatocellular carcinoma (HCC). They found that low serum albumin levels are significant independent biomarkers for poor prognosis in HCC patients. The study emphasized the need for reliable biomarkers to improve treatment outcomes for these patients.
Researchers reviewed the common indications for ordering serum albumin levels in critically ill patients and evaluated the supporting literature. They found that serum albumin is a general marker of illness severity and that hypoalbuminemia is associated with poor outcomes. However, they concluded that there is limited justification for routinely ordering serum albumin levels in ICU settings.
Researchers used Mendelian randomization to investigate the causal relationship between serum albumin levels and cardiovascular diseases. They found that lower serum albumin levels are linked to increased risks of conditions like pulmonary heart disease and stroke. The study underscores the importance of serum albumin as a predictive factor for cardiovascular health.
This study investigated the association between the red cell distribution width/serum albumin ratio and Parkinson's disease. Researchers found that higher ratios were significantly associated with Parkinson's disease and suggested that this ratio could serve as a potential screening tool for increased risk of the condition.
1
Total Trials
150
Total Enrolled
Harran University
150
2024
Primary outcome
Research publications about Albumin over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer